Literature DB >> 23324103

Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.

G Andrésdóttir1, S J L Bakker, H P Hansen, H-H Parving, P Rossing.   

Abstract

AIMS: Hydrogen sulphide levels are reduced in many disease states, including diabetes and end-stage renal disease. We aimed to determine whether urinary sulphate excretion, as a proxy for hydrogen sulphide, was associated with progression of diabetic nephropathy.
METHODS: We conducted a post-hoc study of a prospective, randomized, controlled trial on the effect of a low vs. normal protein diet for 4 years, on decline of renal function in patients with Type 1 diabetes and diabetic nephropathy. We excluded patients with less than three measurements of glomerular filtration rate assessed by (51)Cr-EDTA plasma clearance (GFR) and less than 1 year of follow-up (n = 10), leaving 72 patients eligible for analyses. We studied both association of rate of decline in GFR and association of the combined endpoint of end-stage renal disease and death with baseline 24-h urinary sulphate excretion.
RESULTS: Sulphate excretion was significantly associated with the slope of GFR (rs = -0.28, P = 0.02). In a multivariate regression model, sulphate excretion was a significant determinant of decline in GFR, independent of age, gender, blood pressure, HbA1c , smoking, albuminuria, baseline GFR and diet group (P < 0.01). In addition, adjusted r(2) increased from 5% in a model with the aforementioned risk factors to 22% when sulphate excretion was included in the model. Cox regression revealed a hazard ratio of 0.34 (95% CI 0.13-0.88, P = 0.026) for each natural log unit increase in urinary sulphate excretion.
CONCLUSION: High urinary sulphate excretion was significantly associated with slower decline in (51)Cr-EDTA-assessed GFR in diabetic nephropathy, independent of known progression promoters.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324103     DOI: 10.1111/dme.12131

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  The fate of sulfate in chronic heart failure.

Authors:  Anne M Koning; Wouter C Meijers; Isidor Minović; Adrian Post; Martin Feelisch; Andreas Pasch; Henri G D Leuvenink; Rudolf A de Boer; Stephan J L Bakker; Harry van Goor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

2.  Urinary Sulfate, Kidney Failure, and Death in CKD: The African American Study of Kidney Disease and Hypertension.

Authors:  Aniqa Azim; Jennifer Murray; Srinivasan Beddhu; Kalani L Raphael
Journal:  Kidney360       Date:  2022-04-27

Review 3.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

Review 4.  Nitric oxide in the normal kidney and in patients with diabetic nephropathy.

Authors:  Paolo Tessari
Journal:  J Nephrol       Date:  2014-09-13       Impact factor: 3.902

Review 5.  Modulation of hydrogen sulfide by vascular hypoxia.

Authors:  Jessica M Osmond; Nancy L Kanagy
Journal:  Hypoxia (Auckl)       Date:  2014-08-25

Review 6.  The Role of Hydrogen Sulfide in Renal System.

Authors:  Xu Cao; Jin-Song Bian
Journal:  Front Pharmacol       Date:  2016-10-18       Impact factor: 5.810

7.  Urinary sulfate excretion and risk of late graft failure in renal transplant recipients - a prospective cohort study.

Authors:  M Yusof Said; Adrian Post; Isidor Minović; Marco van Londen; Harry van Goor; Douwe Postmus; M Rebecca Heiner-Fokkema; Else van den Berg; Andreas Pasch; Gerjan Navis; Stephan J L Bakker
Journal:  Transpl Int       Date:  2020-03-23       Impact factor: 3.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.